<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03940222</url>
  </required_header>
  <id_info>
    <org_study_id>SBMU.12345</org_study_id>
    <nct_id>NCT03940222</nct_id>
  </id_info>
  <brief_title>Comparison Between Patching and Interactive Binocular Treatment (IBiTTM) in Amblyopia</brief_title>
  <official_title>Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of amblyopia therapy on cases who will
      receive Interactive Binocular Treatment (IBiTTM) without patching compared with those who
      will receive standard patching of the dominant eye with placebo IBiTTM.

      In this randomized clinical trial, 40 unilateral amblyopic children (3 to 10 years old) will
      be studied. All unilateral functional amblyopic children with best corrected visual acuity
      (BCVA) worse than 0.30 LogMAR at least in one eye or a difference of two BCVA lines of
      Snellen between the two eyes will be included and randomly will divide into the case (n=19)
      and control (n=21) groups. Cases will play I-BiTâ„¢ games, while controls will have standard
      patch therapy and will play with placebo IBiTTM for one month. All subjects will be underwent
      comprehensive ophthalmic examinations at baseline and at one-month follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 2019</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Best Corrected Visual Acuity</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>The New Treatment in Amblyopia Therapy</condition>
  <arm_group>
    <arm_group_label>I-BiT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amblyopic patients will play I-BiT games without patching.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Amblyopic patients will patch their dominant eye and they will play placebo I-BiT games.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Interactive Binocular Treatment</intervention_name>
    <description>The specified system which stimulate the fovea of the amblyopic eye directly by detailed and movable objects, while the fixation of the non- amblyopic eye will be focused on fixed targets.</description>
    <arm_group_label>I-BiT group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Patching Therapy</intervention_name>
    <description>Patching of the dominant eye with better best corrected visual acuity</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Functional amblyopia with BCVA less than 20/30 (0.3 LogMAR) at least in one eye

          -  A difference of two BCVA lines of Snellen between the two eyes

        Exclusion Criteria:

          -  A history of penalization one month prior to the study

          -  Bilateral amblyopia

          -  BCVA less than 20/200

          -  Eccentric fixation

          -  Nystagmus

          -  Ocular deviation more than 10 prism diopter (pd)

          -  Organic amblyopia

          -  Uncooperative children those with

          -  Mental and physical disability

          -  Systemic diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hamideh Sabbaghi, PhD</last_name>
    <phone>989120285930</phone>
    <email>sabbaghi.opt@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hamideh Sabbaghi</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hamideh Sabbaghi</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 3, 2019</study_first_submitted>
  <study_first_submitted_qc>May 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2019</study_first_posted>
  <last_update_submitted>May 4, 2019</last_update_submitted>
  <last_update_submitted_qc>May 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Hamideh Sabbaghi</investigator_full_name>
    <investigator_title>PhD student, Teacher Assistant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

